Federal Judge Approves $345 Million EpiPen Settlement by Pfizer

A federal judge has cleared Pfizer’s $345 million settlement resolving claims the drugmaker overcharged for its EpiPen epinephrine self-injector for treatment of severe allergic reactions.
Source: Drug Industry Daily